Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
作者： Aine M. Kelly , Ben Dwamena , Paul Cronin , Steven J. Bernstein , Ruth C. Carlos
DOI: 10.7326/0003-4819-148-4-200802190-00007
关键词: Surgery 、 Drug 、 Contrast-induced nephropathy 、 Kidney disease 、 Medicine 、 Intensive care medicine 、 Nephropathy 、 Heart failure 、 Randomized controlled trial 、 Clinical trial 、 Meta-analysis
摘要: Contrast-induced nephropathy is a common cause of acute renal failure in hospitalized patients. Clinicians use many drugs to reduce the risk for condition, including N-acetylcysteine, theophyll...
sci-hub.se 参考文章(64)
H Jolly, L Rojo, T Diez, R Marcucci, M Ramos, M Diab, D Bagilet, Evaluation of two methods to avoid the nephropathy associated with radiologic contrast Medicina-buenos Aires. ,vol. 59, pp. 55- 58 ,(1999)
Alexandre D Azmus, Andre Manica, Carlos Gottschall, Marcos Frey, Lauro Bulcão, Kaue Duro, Cristiane Lima, João Manica, Effectiveness of acetylcysteine in prevention of contrast nephropathy. Journal of Invasive Cardiology. ,vol. 17, pp. 80- ,(2005)
G Helft, F Beygui, J P Metzger, J P Batisse, C Le Feuvre, K H Le Quan Sang, R El Mahmoud, [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography]. Archives Des Maladies Du Coeur Et Des Vaisseaux. ,vol. 96, pp. 1157- 1161 ,(2003)
Sang-Ho Jo, Tae-Jin Youn, Bon-Kwon Koo, Jin-Shik Park, Hyun-Jae Kang, Young-Seok Cho, Woo-Young Chung, Gwon-Wook Joo, In-Ho Chae, Dong-Ju Choi, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, Hyo-Soo Kim, Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. Journal of the American College of Cardiology. ,vol. 48, pp. 924- 930 ,(2006) , 10.1016/J.JACC.2006.06.047
Arianne P. Verhagen, Henrica C.W. de Vet, Robert A. de Bie, Alphons G.H. Kessels, Maarten Boers, Lex M. Bouter, Paul G. Knipschild, The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Journal of Clinical Epidemiology. ,vol. 51, pp. 1235- 1241 ,(1998) , 10.1016/S0895-4356(98)00131-0
Joëlle M. KEFER, Claude E. HANET, Sabine BOITTE, Léon WILMOTTE, Martine DE KOCK, Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient? Acta Cardiologica. ,vol. 58, pp. 555- 560 ,(2003) , 10.2143/AC.58.6.2005321
R. Solomon, C. Biguori, M. Bettmann, Selection of contrast media. Kidney International. ,vol. 69, ,(2006) , 10.1038/SJ.KI.5000373
Melissa A. Stevens, Peter A. McCullough, Kenneth J. Tobin, John P. Speck, Douglas C. Westveer, Debra A. Guido-Allen, Gerald C. Timmis, William W. O’Neill, A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy Journal of the American College of Cardiology. ,vol. 33, pp. 403- 411 ,(1999) , 10.1016/S0735-1097(98)00574-9
K. Spargias, E. Adreanides, G. Giamouzis, S. Karagiannis, A. Gouziouta, A. Manginas, V. Voudris, G. Pavlides, D. V. Cokkinos, Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study European Journal of Clinical Pharmacology. ,vol. 62, pp. 589- 595 ,(2006) , 10.1007/S00228-006-0150-Y
Louis C. Coyle, Antonio Rodriguez, Robert E. Jeschke, Anabela Simon-Lee, Kevin C. Abbott, Allen J. Taylor, Acetylcysteine In Diabetes (AID): A randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics American Heart Journal. ,vol. 151, pp. 1032- ,(2006) , 10.1016/J.AHJ.2006.02.002